Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 914 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Gilead Submits sNDA for Truvada

According to the company, Truvada once approved would be the first agent indicated for uninfected individuals to reduce the risk of acquiring HIV through sex, a prevention approach

MorphoSys, Novozymes enter Slonomics technology deal

As per the terms of the collaboration, Novozymes receives non-exclusive license to use MorphoSys’s Slonomics technology to develop novel products within the industrial biotechnology sector. The Advanced Protein

Vertex Kalydeco gets FDA NDA approval

The FDA has also granted the company’s request for six-month Priority Review of Kalydeco, acts by targeting the defective protein that causes CF. The move follows the results

CCGroup to launch Cave Grouper free version

CaveGrouper-Lite groups over 15,000 ICD-9 and 68,000 ICD-10 diagnosis codes into meaningful medical conditions that account for 100% of all medical conditions and expenditures. The software builds longitudinal